Mcf Advisors LLC Laboratory Corp Of America Holdings Transaction History

Mcf Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	BUY	$209.01 - $232.56 $209 - $232	1 Added 1.09%	93 $20,000
Q3 2023 Oct 19, 2023	BUY	$201.05 - $221.7 $201 - $221	1 Added 1.1%	92 $18,000
Q4 2022 Jan 31, 2023	SELL	$203.72 - $248.97 $814 - $995	-4 Reduced 4.21%	91 $21,000
Q3 2022 Nov 09, 2022	BUY	$204.81 - $262.19 $204 - $262	1 Added 1.06%	95 $19,000
Q1 2022 May 05, 2022	BUY	$259.82 - $298.18 $24,423 - $28,028	94 New	94 $24,000
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $25,530 - $29,535	-94 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$274.82 - $308.34 $1,099 - $1,233	4 Added 4.44%	94 $26,000
Q1 2020 Apr 24, 2020	BUY	$104.32 - $195.28 $9,388 - $17,575	90 New	90 $11,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.7B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Mcf Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Mcf Advisors LLC with notifications on news.